1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Spain >
  5. TiGenix N.V. Acquires Cellerix S.A.

M&A Deal Summary

TiGenix N.V. Acquires Cellerix S.A.

On May 5, 2011, TiGenix N.V. acquired life science company Cellerix S.A.

Acquisition Highlights
  • This is TiGenix N.V.’s 2nd transaction in the Life Science sector.
  • This is TiGenix N.V.’s 2nd transaction in Spain.

M&A Deal Summary
Date 2011-05-05
Target Cellerix S.A.
Sector Life Science
Buyer(s) TiGenix N.V.
Deal Type Add-on Acquisition

Target

Cellerix S.A.

Tres Cantos, Spain
Cellerix S.A. is a biotechnology company, engages in the development and production of medicines based on the use of stem cells of adult origin.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

TiGenix N.V.

Leuven, Belgium
Category Company
Founded 2000
Sector Life Science
Revenue 6M EUR (2014)
DESCRIPTION

TiGenix N.V. is a European cell therapy company with a proprietary validated allogeneic expanded adipose-derived stem cell (eASC) platform technology for the treatment of autoimmune and inflammatory diseases, and a commercialized product. TiGenix was formed in 2000 and is based in Leuven, Belgium.

DEAL STATS #
Overall 3 of 3
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 3 of 3
Country: Spain M&A 2 of 2
Year: 2011 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-05-05 Coretherapix S.L.

Madrid, Spain

Coretherapix S.L. engages in creation and development of stents coated medications for cardiac regeneration. The company is based in Spain.

Buy -
Mergr

Solution for

Product

Company

Legal